The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-Kras G12D/+ transgenic mouse model
Altaf Mohammed, Naveena B. Janakiram, Qian Li, Venkateshwar Madka, Misty Ely, Stan Lightfoot, Howard Crawford, Vernon E. Steele, Chinthalapally V. Rao
Dive into the research topics of 'The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-Kras G12D/+ transgenic mouse model'. Together they form a unique fingerprint.